Cargando…
Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
The use of thiazolidinedione (TZD) therapy in type II diabetic patients has proven useful in the lowering of blood glucose levels. However, recent investigations have shown that there may be potential health concerns associated, including the risk of developing bladder cancer as well as complication...
Autores principales: | Chiu, Melody, McBeth, Lucien, Sindhwani, Puneet, Hinds, Terry D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350343/ https://www.ncbi.nlm.nih.gov/pubmed/28348577 http://dx.doi.org/10.1155/2017/4810672 |
Ejemplares similares
-
Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
por: Wei, Wei, et al.
Publicado: (2011) -
Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis
por: Hinds, Terry D., et al.
Publicado: (2016) -
PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors
por: Lichtor, Terry, et al.
Publicado: (2008) -
Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer
por: McBeth, Lucien, et al.
Publicado: (2015) -
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?
por: Sundararaghavan, Vikram L., et al.
Publicado: (2016)